AMSTERDAM, August 19, 2015 /PRNewswire/ --

First issue covers a Symposium of research around the history of the first IVF births  

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announces the launch of open access journal Reproductive Biomedicine & Society Online.

Reproductive Biomedicine & Society Online is an online-only journal focusing on interdisciplinary discussion and debate of the rapidly expanding field of reproductive biomedicine, particularly all of its many societal and cultural implications. It is intended to bring to attention new research in the social sciences, arts and humanities on human reproduction, new reproductive technologies, and related areas such as human embryonic stem cell derivation. Its audience comprises researchers, clinicians, practitioners, policy makers, academics and patients.

The main disciplines covered in Reproductive Biomedicine & Society Online are: Social Sciences and Humanities concerning reproductive bioscience and medicine. The subject areas include: Politics Sociology and Social Policy, Philosophy, Anthropology, Psychology, the Arts, History, Ethics and Law as related to reproductive biomedicine.

Greyling Peoples, Publisher at Elsevier, said, "We are excited about the launch of RBMS and the editorial stewardship of Professors Sarah Franklin and Martin Johnson. They have assembled a dynamic and impressive editorial panel that will inspire scholarly excellence in the expanding field of reproductive biomedicine."

Excited by the journal's potential to advance the field, Professor Franklin said, "There is increasing interdisciplinary cooperation in the study of reproductive biomedicine - including its international histories, ethics and politics, social and cultural dimensions, regulation and governance, literary and artistic representation, and future demographic implications. RBMS will help lead this growing trend worldwide."  

Professor Johnson added, "RBMS's role will be to widen the debate around subjects such as the commercialization of fertility technologies, infertility and health inequalities, cross-border reproductive care, and the new 'kinships' arising out of new forms of assisted reproduction which was a priority for Bob Edwards. "

The first issue is a Symposium of extensive historical research on the Oldham laboratory notebooks and archival materials leading back to the first IVF births.  

For more information or to submit an article, go to: http://www.rbmsociety.com/

The first issue of Reproductive Biomedicine & Society Online is available online on ScienceDirect.

About Open Access Publishing at Elsevier 

Elsevier has been providing open access publishing options since 2005. Today, researchers can choose to publish open access in over 1,600 established peer-reviewed journals as well as over 300 open access journals and these numbers will continue to grow rapidly. All of Elsevier's open access publications have been peer reviewed, ensuring that the broader community not only reads the latest research but that it is factual, original and of the highest quality and ethical standards. For more information about Elsevier's open access program, visit http://www.elsevier.com/openaccess

About Elsevier 

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions - among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey - and publishes more than 2,500 journals, including The Lancet and Cell, and more than 33,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group plc, a world-leading provider of information solutions for professional customers across industries. http://www.elsevier.com

Media contact
Wendy Montalvo
Elsevier
+1-212-633-3981
montalvow@reedelsevier.com

SOURCE Elsevier